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Abstract
In this modern world, due to the rapid advancement of civilization, industrialization, and
overpopulation, scientific knowledge on antioxidants is important since most of the dis‐
eases are mediated through reactive oxygen species (ROS). An antioxidant is a molecule
that inhibits the oxidation of another molecule. Antioxidants may work through single or
combined mechanisms, and based on their activity, they have been categorized into pri‐
mary, secondary, and tertiary antioxidants. Enzymatic and non-enzymatic antioxidants
are the two widely accepted categories of antioxidants. In addition to natural antioxi‐
dants, synthetic antioxidants have been extensively used in medicinal and food indus‐
tries. In brief, antioxidants play a significant role in ameliorating toxicity through free
radical scavenging reactions and therefore have potential therapeutic value.
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1. Introduction
Halliwell and Gutteridge [1] defined antioxidants as “any substance that delays, prevents or
removes oxidative damage to a target molecule” [1, 2]. Khlebnikov et al. [3] defined antioxi‐
dants as “any substance that directly scavenges ROS or indirectly acts to up-regulate antioxi‐
dant defenses or inhibit ROS production”. In other words, we can define antioxidants as any
molecule that inhibits the oxidation of another molecule. A chemical reaction involving the
loss of electrons and increase in the oxidative state is termed as “oxidation.” Oxidation results
in the formation of free radicals that are unstable atoms and molecules deficit in electrons.
They have unpaired electrons and are extremely reactive and are capable of initiating chain
reactions that destabilize other molecules and generate free radicals. These free radicals are
also termed as reactive oxygen species or ROS and create a homeostatic imbalance that
generates oxidative stress and causes cell death and tissue injury. ROS includes: superoxide
(O2 ⋅−), hydroxyl (OH⋅), peroxyl (RO2 ⋅), hydroperoxyl (HO2 ⋅), alkoxyl (RO⋅), peroxyl
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(ROO⋅), nitric oxide (NO⋅), nitrogen dioxide (NO2 ⋅), and lipid peroxyl (LOO⋅) and the non-
radicals hydrogen peroxide (H2O2), hypochlorous acid (HOCl), ozone (O3), singlet oxygen
(1Δg), and lipid peroxide (LOOH) [4]. Free radicals are known to be formed as a result of
environmental pollution, stress, cigarette smoke, UV Light, ionizing radiations, and xenobi‐
otics. Toxic effect of the free radicals causes oxidative stress and results in the pathogenesis of
diseases (Figure 1).
Figure 1. Free radicals: Production and damage (Adapted from [5]).
Involvement of ROS is implicated in neurodegenerative and other disorders such as Alzheim‐
er’s disease, Parkinson’s disease, multiple sclerosis, Down syndrome, inflammation, viral
infection, autoimmune pathology, and digestive ulcers. Recent developments in biomedical
science emphasize the involvement of free radicals in many diseases, such as brain dysfunc‐
tion, cancer, heart disease, and immune system [6]. Antioxidants normally terminate many
reactions by removing free radical intermediates and inhibit other oxidation reactions. Thus,
antioxidants often serve as reducing agents (examples: thiols, ascorbic acid, or polyphenols)
[7]. Depending on the balance between ROS and the availability of antioxidants in the
microenvironment of the cell, antioxidants can inhibit or delay the initiation or propagation
of oxidative chain reaction and thus prevent or repair cell damage caused by reactive oxygen
[8]. Antioxidants have been reported to work through single or combined mechanisms,
namely, free radical scavenging, reducing activity, complexing of pro-oxidant, scavenging
lipid peroxyl radicals, and quenching of singlet oxygen. Preventive oxidants are the antioxi‐
dants that act as inhibitors of free radical oxidation reactions. Chain-breaking antioxidants
inhibit formation of free lipid radicals as follows: by obstructing the propagation of the
autoxidation chain reactions; as singlet oxygen quenchers; as reducing agents which convert
hydroperoxides into stable compounds; as metal chelators that convert metal pro-oxidants
(iron and copper derivatives) into stable products; and finally as inhibitors of pro-oxidative
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enzymes (lipoxygenases) [9]. Antioxidant approach to disease management holds potential as
most of the diseases are mediated through ROS, also with the rapid advancement of civiliza‐
tion, industrialization, and overpopulation. Epidemiological researches strongly suggest that
foods containing antioxidants and scavengers have a potential protective effect against
disorders caused by ROS [10].
1.1. Classification of antioxidants
Guttering and Halliwell classified the antioxidants into three categories: primary, secondary,
and tertiary antioxidants [11]. Primary antioxidants are involved in the prevention of oxidant
formation; secondary antioxidants are known to be scavengers of ROS, and tertiary antioxi‐
dants repair the oxidized molecules through sources like dietary or consecutive antioxidants.
Antioxidants may also be classified as enzymatic or non-enzymatic antioxidants (Figure 2).
1.1.1. Enzymatic antioxidants
The antioxidant enzymatic system directly/indirectly contributes to defense against the ROS.
Catalase, superoxide dismutase (SOD), glutathione peroxidase, glutathione reductase, etc., are
enzymatic antioxidants.
1.1.2. Non-enzymatic antioxidants
These antioxidants are quite a few, namely vitamins (A, C, E, and K), enzyme cofactors (Q10),
minerals (Zn, Se, etc.), organosulfur compounds (allium and allium sulfur), nitrogen com‐
pounds (uric acid), peptides (glutathione), and polyphenols (flavonoids and phenolic acid).
1.1.3. Hydrophilic antioxidants
Antioxidants that react with oxidants in the cell cytoplasm and the blood plasma are termed
as hydrophilic antioxidants (ascorbic acid, glutathione, and uric acid).
1.1.4. Hydrophobic antioxidants
These compounds are known to protect cell membranes from lipid peroxidation (ubiqui‐
nol, carotenes, and α-tocopherol). They are obtained either from the diet or synthesized in
the body [12].
1.1.5. Endogenous antioxidants
Endogenous antioxidants can be categorized into primary antioxidants and secondary
antioxidants. Primary antioxidants inactivate the ROS into their intermediates. SOD, catalase,
and glutathione peroxidase are the primary antioxidant enzymes [13]. They can be water
soluble or lipid soluble (ascorbate, glutathione, uric acid, etc., are water soluble, and toco‐
pherols, ubiquinols, and carotenoids, etc., are lipid soluble). Secondary antioxidant enzymes
act directly to detoxify ROS. They maintain their proper functioning by decreasing the
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peroxides level and continuously supplying NADPH (nicotinamide adenine dinucleotide
phosphate) and glutathione for primary antioxidant enzymes. Glutathione reductase, glu‐
cose-6-phosphate dehydrogenase, glutathione-s-transferase, and ubiquinone are the secon‐
dary antioxidants. Iron, copper, zinc, manganese, and selenium also increase the antioxidant
enzyme activities [14, 15].
1.1.6. Exogenous antioxidants
Many foods and various dietary components exhibit antioxidant activities. Several herbs,
spices, vitamins, foods, vegetables, etc., are reported to be sources of exogenous antioxidants.
These antioxidant drugs could be used for the treatment of various pathological diseases, and
therefore gained importance in clinical as well as research areas. Many polyphenolic com‐
pounds such as flavonoids, isoflavones, flavones, anthocyanins, coumarins, lignans, catechins,
isocatechins, epicatechins, and phenolic acids such as hydrocinnamic acid, hydrobenzoic acid,
gallic acid, ellagic acid, etc., have gained importance as antioxidant phytochemicals. These
bioactive compounds are being tested in clinical and preclinical trials. Plant-derived drugs are
medicinally useful as they contain phytochemicals like terpenoid, alkaloids, glycosides,
polyphenolics, and steroids and are of great significance in research area [16, 17]. Dietary
nutrients, protein, and amino acids are responsible for the synthesis of antioxidant enzymes
and hence play an important role in the defensive mechanism. GSH, creatine, and uric acid act
as the direct scavengers of reactive metabolites [18]. Antioxidants of natural origin such as
polyphenols, tannins, and flavonoids act by donating electrons to the intermediate radicals
formed in oxidative stress or tissue damage that help in inhibition of the lipid peroxidation.
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Figure 2. Antioxidants: Classification (Adapted from [19]).
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2. Enzymatic and non-enzymatic antioxidants
When cells are exposed to oxidative stress, a defense system endorses the expression and
regulation of a number of antioxidant enzymes as a defense mechanism to protect them from
the damage induced by free radicals. These antioxidant defenses could be non-enzymatic or
enzymatic (Table 1).
2.1. Enzymatic antioxidants
Enzymatic antioxidants are categorized into primary and secondary enzymatic defenses.
Primary defense is composed of three important enzymes that prevent the formation or
neutralize free radicals: glutathione peroxidase, which donates two electrons to reduce
peroxides by forming selenols and also eliminates peroxides; catalase, which converts
hydrogen peroxide into water and molecular oxygen; and SOD, which converts superoxide
anions into hydrogen peroxide as a substrate for catalase [20].
Glutathione reductase and glucose-6-phosphate dehydrogenase are involved in the secondary
enzymatic defense system. Glutathione reductase reduces glutathione (antioxidant) from its
oxidized form to its reduced form, thereby recycling itself to continue neutralizing more free
radicals. Glucose-6-phosphate regenerates NADPH (a coenzyme used in anabolic reactions)
creating a reducing environment [21, 22]. These two enzymes do not neutralize free radicals
directly but have supporting roles to other endogenous antioxidants.
Glutathione peroxidase, catalase, and SOD metabolize toxic oxidative intermediates and
therefore form the primary antioxidant enzymes. These form the body’s endogenous defense
mechanism and help protect against free radical-induced cell damage. For optimum catalytic
activity, these enzymes also require co-factors such as selenium, iron, copper, zinc, and
manganese. It has been indicated that an inadequate dietary intake of these trace minerals may
compromise the effectiveness of these antioxidant defense mechanisms. The consumption and
absorption of important trace minerals may decrease with aging.
2.1.1. Superoxide dismutase
The superoxide dismutases catalyze the dismutation of superoxide to hydrogen peroxide:
2 2 2 2 2O O 2H H O O .+- -+ + ® +
Catalase or glutathione peroxidase removes hydrogen peroxide. Catalase converts hydrogen
peroxide into water and molecular oxygen.
Mammalian tissues have three forms of superoxide dismutase, each with a specific subcellular
location and different tissue distribution (Figure 3).
1. Copper zinc superoxide dismutase (CuZnSOD): CuZnSOD has a molecular mass of
approximately 32,000 kDa and has two protein subunits, each containing a catalytically
active copper and zinc atom and is present in the cytoplasm and organelles of all mam‐
malian cells.
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2. Manganese superoxide dismutase (MnSOD): MnSOD is found to have a molecular mass
of 40,000 kDa. It consists of four protein subunits, each probably containing a single
manganese atom. It is present in the mitochondria of almost all cells [23]. The amino acid
sequence of MnSOD is very dissimilar to that of CuZnSOD and is not inhibited by cyanide,
and thereby MnSOD activity can be distinguished from that of CuZnSOD in mixtures of
the two enzymes.
3. Extracellular superoxide dismutase (ECSOD): Marklund described EC-SOD in 1982 [24].
It is a secretory copper and zinc containing SOD and is different from the CuZnSOD. Only
a few cell types, including fibroblasts and endothelial cells, synthesize EC-SOD and are
expressed on the cell surface where it is bound to heparin sulfates. EC-SOD is the major
SOD detectable in extracellular fluids and following the injection of heparin, it is released
into the circulation from the surface of vascular endothelium [25]. EC-SOD might play a
role in the regulation of vascular tone because endothelial derived relaxing factor (nitric
oxide or a closely related compound) is neutralized in the plasma by superoxide [26].
These superoxide enzymes are present in extracellular fluids of almost all aerobic cells. SODs
contain metal ion cofactors like copper, zinc, manganese, or iron depending on the isozyme.
For example, in human copper/zinc SOD is present in the cytosol while manganese SOD is
present in the mitochondrion. The mitochondrial SOD is the most biologically significant of
these three enzymes. SOD isozymes are present in the cytosol and mitochondria in plants, and
there is also an iron SOD found in chloroplasts.
2.1.2. Catalase
Catalase was the first antioxidant enzyme to be characterized and catalyzes the two-stage
conversion of hydrogen peroxide to water and oxygen. Catalases are enzymes that catalyze
the conversion of hydrogen peroxide to water and oxygen, using either an iron or manganese
cofactor. Here, its cofactor is oxidized by one molecule of hydrogen peroxide and then
regenerated by transferring the bound oxygen to a second molecule of substrate.
( )
( )
2 2
2 2 2 2
Catalase–Fe III  + H O  compound I
Compound I+H O  catalase–Fe III  + 2H O+O .
®
®
Catalase consists of four protein subunits, each containing a heme group and a molecule of
NADPH [27]. Catalase is largely located within cells in peroxisomes, which also contain most
of the enzymes capable of generating hydrogen peroxide. The greatest activity is present in
the liver and erythrocytes, but some catalase is found in all tissues. It is a tetrameric enzyme
consisting of four identical tetrahedrally arranged subunits of 60 kDa, which contains a single
ferriprotoporphyrin group per subunit and has a molecular mass of about 240 kDa
2.1.3. Glutathione enzymes
The glutathione system includes glutathione, glutathione reductase, glutathione peroxidases,
and glutathione “s”-transferases. Glutathione peroxidase is an enzyme containing four
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selenium cofactors that catalyze the breakdown of hydrogen peroxide and organic hydroper‐
oxides. Glutathione “s”-transferases show high activity with lipid peroxides. These enzymes
are noticed especially in high levels in the liver. Glutathione peroxidases catalyze the oxidation
of glutathione. Hydroperoxides, such as hydrogen peroxide and lipid hydroperoxides, act as
substrates for these enzymes [28].
2ROOH + 2GSH  GSSG + H O + ROH.®
Selenium is required at the active site for effective functioning of glutathione peroxidases [29].
Kidney synthesizes the plasma form of glutathione, and the highest level of glutathione
peroxidases is found within liver cells, although glutathione peroxidase is widely distributed
in almost all tissues. Glutathione peroxidase is the main scavenger of hydrogen peroxide in
these subcellular compartments; the predominant sub-cellular distribution is in the cytosol
and mitochondria. The activity of the enzyme glutathione peroxidase is dependent on the
constant availability of reduced glutathione [30].
+ + +GSSG + NADPH H  2GSH + NADP .®
The NADPH required by this enzyme to restore the supply of reduced glutathione is supplied
by the pentose phosphate pathway. Glutathione reductase is a flavine nucleotide-dependent
enzyme and has a similar tissue distribution to glutathione peroxidase [31].
Amino acids such as glycine, glutamate, and cysteine are utilized in the synthesis of gluta‐
thione. It is an important water-soluble antioxidant that plays a major role in xenobiotic
metabolism; it can directly neutralize ROS such as lipid peroxide. When a body is exposed to
xenobiotics or toxins, there is an increase in the level of detoxification enzymes (cytochrome
P-450 mixed-function oxidase). Xenobiotics conjugate with glutathione, and hence a higher
concentration of the enzyme is required for conjugation to make the toxin neutral and thereby
making the enzyme less available as an antioxidant. Glutathione and vitamin C work interac‐
tively to neutralize the free radicals.
2.1.4. Non-enzymatic endogenous antioxidants
There are a number of non-enzymatic antioxidants: vitamins (A, C, E, and K), enzyme cofactors
(Q10), minerals (Zn and Se), organosulfur compounds (allium and allium sulfur), nitrogen
compounds (uric acid), peptides (glutathione), and polyphenols (flavonoids and phenolic
acid).
2.1.4.1. Vitamin A
Vitamin A is produced as a result of the breakdown of β-carotene and is a carotenoid produced
in the liver. It exhibits antioxidant activity due to its ability to combine with peroxyl radicals
before they propagate peroxidation to lipids. Vitamin A is known to have a beneficial impact
on the skin, eyes, and internal organs [32, 33].
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2.1.4.2. Coenzyme Q10
Coenzyme Q10 has been reported to act by preventing the formation of lipid peroxyl radicals.
It neutralizes the radicals even after their formation. An important role of this coenzyme is
regeneration of vitamin E. Regeneration of vitamin E through this process is more likely than
through ascorbate (vitamin C). This coenzyme is present in all cells and membranes and plays
an important role in the respiratory chain and other cellular metabolism processes [34].
2.1.4.3. Uric acid
The end product of purine nucleotide metabolism in humans is uric acid. After undergoing
kidney filtration, 90% of the uric acid is reabsorbed by the body, proving that it has important
functions within the body. Uric acid prevents lysis of erythrocytes by peroxidation and is a
potent scavenger of singlet oxygen and hydroxyl radicals. It is also known to prevent the
overproduction of oxo-heme oxidants that result from the reaction of hemoglobin with
peroxides [35].
2.1.4.4. Glutathione
Glutathione is an endogenous tripeptide that protects the cells against free radicals by donating
either a hydrogen atom or an electron. It also plays an important role in the regeneration of
other antioxidants like ascorbate [36]. However, the endogenous antioxidant system is not
sufficient; humans depend on dietary antioxidants to reduce free radical concentrations [37].
2.1.4.5. Vitamin C
Ascorbic acid and tocopherols are generic names for vitamin C and vitamin E. Ascorbic acid
consists of two antioxidant compounds: L-ascorbic acid and L-dehydroascorbic acid. These
two compounds are absorbed through the gastrointestinal tract and can be interchanged
enzymatically in vivo. Ascorbic acid acts by scavenging the superoxide radical anion, hydrogen
peroxide, hydroxyl radical, singlet oxygen, and reactive nitrogen oxide [38].
2.1.4.6. Vitamin E
Vitamin E is the only major lipid-soluble, chain-breaking antioxidant found in plasma, red
cells, and tissues, thus protecting the integrity of lipid structures, mainly membranes. It inhibits
lipid peroxidation by donating its phenolic hydrogen to the peroxyl radicals forming toco‐
pheroxyl radicals that, despite also being radicals, are unreactive and unable to continue the
oxidative chain reaction. There are eight isoforms of vitamin E: four tocopherols (α-tocopherol,
β-tocopherol, γ-tocopherol, and δ-tocopherol) and four tocotrienols (α-tocotrienol, β-tocotrie‐
nol, γ-tocotrienol, and δ-tocotrienol), α- tocopherol being the most potent and abundant
isoform in biological systems. The antioxidant activity of tocopherols is due to the chroman
head, but the phytyl tail has no effect [39]. These two vitamins also display a synergistic
behavior with the regeneration of vitamin E through vitamin C from the tocopheroxyl radical
to an intermediate form, therefore reinstating its antioxidant potential [40].
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2.1.4.7. Vitamin K
This vitamin has two natural isoforms: vitamins K1 and K2. Vitamin K is a group of fat-soluble
compounds, essential for the post-translational conversion of protein-bound glutamates into
γ-carboxyglutamates in various target proteins. The antioxidant activity is due to the 1, 4-
naphthoquinone structure of these vitamins [41].
2.1.4.8. Flavonoids
Flavonoids are a group of compounds composed of diphenyl propane (C6C3C6) skeleton. It
can be classified as flavonols, flavanols, anthocyanins, isoflavonoids, flavanones, and flavones.
Flavanones and flavones are usually found in the same fruits and are connected by specific
enzymes while flavones and flavonols do not share this phenomenon and are rarely found
together. Anthocyanins are also absent in flavanone-rich plants. Flavonoids exhibit their
antioxidant activity due to the phenolic hydroxyl groups attached to ring structures. They may
act as reducing agents, superoxide radical scavengers, hydrogen donators, singlet oxygen
quenchers, and also as metal chelators. They activate antioxidant enzymes, reduce α-toco‐
pherol radicals (tocopheroxyls), inhibit oxidases, mitigate nitrosative stress, and increase the
levels of uric acid and low-molecular-weight molecules. Some of the flavonoids of significance
are quercetin, kaempferol, catechin, and catechin-gallate [42, 43].
2.1.4.9. Phenolic acids
Phenolic acids are composed of hydroxycinnamic and hydroxybenzoic acids. One of the most
studied and promising compounds in the hydroxybenzoic group is gallic acid that is also the
precursor of many types of tannin, while cinnamic acid is the precursor of all the hydroxycin‐
namic acids. They are present in plant material and sometimes present as esters and glycosides.
They have antioxidant activity as chelators and free radical scavengers with special impact
over hydroxyl and peroxyl radicals, superoxide anions, and peroxynitrites [44, 45].
2.1.4.10. Carotenoids
Carotenoids are a group of natural pigments and are synthesized by plants and microorgan‐
isms. They can be classified into two different groups: the carotenoid hydrocarbons known as
the carotenes containing distinct end groups like lycopene and β-carotene; and the oxygenated
carotenoids known as xanthophylls, like zeaxanthin and lutein. Carotenoids display their
antioxidant activity due to singlet oxygen quenching which culminates in excited carotenoids
that dispel the newly acquired energy through a series of rotational and vibrational interactions
with the solvent, thus returning to the unexcited state and allowing them to quench more
radical species. The only free radicals that completely damage these pigments are peroxyl
radicals. Carotenoids are relatively unreactive, but they may also decay and form non-radical
compounds and result in terminating free radical attacks by binding to these radicals [46].
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2.1.4.11. Minerals
Minerals are found in trace quantities in animals and are a small part of dietary antioxidants,
but play significant roles in their metabolism. The most important minerals exhibiting
antioxidant activity are selenium and zinc. Selenium can be found in both organic (selenocys‐
teine and selenomethionine) and inorganic (selenite and selenate) forms in the human body.
It does not act directly on free radicals but is a vital part of most antioxidant enzymes (metal‐
loenzymes, glutathione peroxidase, and thioredoxin reductase) that would have no effect
without it [47].
Various pathways in metabolism require zinc. Zinc is essential in the prevention of free radical
formation and does not directly attack free radicals. Zinc is also an inhibitor of NADPH
oxidases that catalyze the production of the singlet oxygen radical from oxygen by using
NADPH as an electron donor. It is present in SOD, a vital antioxidant enzyme that converts
the singlet oxygen radical into hydrogen peroxide. Zinc brings about the production of
metallothionein that is a scavenger of the hydroxyl radical. Finally, zinc also competes with
copper for binding to the cell wall, thus decreasing the production of hydroxyl radicals [48].
2.1.4.12. Lipoic acid
Lipoic acid and its reduced form, dihydrolipoic acid (DHLA), neutralize the free radicals in
both lipid and aqueous domains and are called “universal antioxidants.” It is categorized as
“thiol” or “biothiol.”
They are sulfur-containing molecules that catalyze the oxidative decarboxylation of alpha-keto
acids, such as pyruvate and alpha-ketoglutarate, in the Krebs cycle.
2.1.4.13. Peroxiredoxins
These may be of three basic types: typical 2-cysteine peroxiredoxins; atypical 2-cysteine
peroxiredoxins; and 1-cysteine peroxiredoxins. Peroxiredoxins are important in antioxidant
metabolism as they catalyze the reduction of hydrogen peroxide, organic hydroperoxides, as
well as peroxynitrite.
2.1.4.14. Synthetic antioxidants
Synthetic antioxidants have been developed to have a standard antioxidant activity measure‐
ment system and to compare with natural antioxidants that are incorporated into food.
Synthetic antioxidants are added to food so that it can withstand various treatments and
conditions to prolong shelf life and prevention of food oxidation, especially fatty acids. It has
been reported that synthetic antioxidants are added to almost all processed foods, which are
reported to be safe, although some studies oppose this fact. The important synthetic antioxi‐
dants are BHT (butylated hydroxytoluene) and BHA (butylated hydroxyanisole). The Euro‐
pean Food Safety Authority (EFSA) between 2011 and 2012 classified an NOAEL (No
Observable Adverse Effect Level) of 0.25 mg/kg BW/day for BHT and 1.0 mg/kg BW/day for
BHA in terms of daily intake and admitted that the exposure of adults and children was
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unlikely to exceed these doses. TBHQ (tert-butylhydroquinone) stabilizes and preserves the
freshness, nutritive value, flavor, and color of animal food products. Octyl gallate is considered
as safe to use as a food additive because, after consumption, it is hydrolyzed into gallic acid
and octanol, which are found in many plants and do not pose a threat to human health [50].
NDGA (nordihydroguaiaretic acid) despite being a food antioxidant is known to cause renal
cystic disease in rodents [51].
2.1.4.15. Pro-oxidants
Pro-oxidants are defined as chemicals that induce oxidative stress, usually through the
formation of reactive species or by inhibiting antioxidant systems. Free radicals are considered
pro-oxidants, but sometimes, antioxidants can also have pro-oxidant behavior. Vitamin C is a
potent antioxidant, but it can also become a pro-oxidant when it combines with iron and copper
reducing Fe3+ to Fe2+ (or Cu3+ to Cu2+), which in turn reduces hydrogen peroxide to hydroxyl
radicals [52].
α-Tocopherol is a powerful antioxidant, but in high concentrations, it can become a pro-
oxidant. When vitamin E reacts with a free radical, it becomes a radical itself, and if there is
not enough ascorbic acid for its regeneration, it will remain in this highly reactive state and
support the autoxidation of linoleic acid [53].
Although not much evidence is found, it is proposed that carotenoids can also display pro-
oxidant effects especially through autoxidation in the presence of high concentrations of
oxygen-forming hydroxyl radicals [54]. Flavonoids may also serve as pro-oxidants. The
occurrence of O2, iron, and copper damages biological molecules [55].
Figure 3. Diagrammatic representation of the site of enzymatic and non-enzymatic antioxidant defense system (Adapt‐
ed from [49]).
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Enzymatic antioxidants Location Properties
Superoxide dismutase (SOD) Mitochondria and cytosol Dismutation of superoxide radicals
Catalase (CAT) Mitochondria and cytosol Removes hydrogen peroxide
Glutathione peroxidase (GSH)) Mitochondria and cytosol Removes hydrogen peroxide and organic
hydroperoxide
Non-enzymatic antioxidants Location Properties
Vitamin C Aqueous phase of cell Acts as a free radical scavenger and recycles
vitamin E
Vitamin E Cell membrane Major chain-breaking antioxidant in cell
membrane
Uric acid Product of purine metabolism Scavenger of OH radicals
Carotenoids Membrane tissue Scavengers of ROS and singlet oxygen
quencher
Glutathione Non-protein thiol in cell Serves multiple roles in the cellular
antioxidant defense
Lipoic acid Endogenous thiol Effectual in recycling vitamin C, and also a
functional glutathione substitute
Metals ions sequestration:
transferrin, ferritin, lactoferrin
Mitochondria and cytosol Scavenger of free radical and inhibitor of lipid
peroxidation
Nitric oxide Mitochondria and cytosol Chelating of metal ions, and responsible for
Fenton reactions
Ubiquinones Mitochondria Reduced form serve as functional antioxidants
Bilirubin Product of heme metabolism in blood Extracellular antioxidant
Table 1. Major enzymatic and non-enzymatic antioxidants (Adapted and modified from [56]).
3. Antioxidant defense mechanism
Free radicals are constantly being generated in the body through various mechanisms and are
also being removed by endogenous antioxidant defensive mechanisms that act either by
scavenging free radicals, by decomposing peroxides, or by binding with pro-oxidant metal
ions (Tables 2 and 3; Figure 4).
Antioxidants are classified into three categories [56–58] as follows:
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1. Primary antioxidants: It is involved in the prevention of oxidant formation. They act by
suppressing the formation of free radicals (examples: glutathione peroxidase, catalase,
selenoprotein, transferrin, ferritin, lactoferrin, carotenoids, etc.).
2. Secondary antioxidants: These exhibit scavengers of ROS. They act by suppressing chain
initiation and breaking chain propagation reactions (radical scavenging antioxidants).
3. Tertiary antioxidants: They act by repairing the oxidized molecules (some proteolytic
enzymes, enzymes of DNA, etc.) through sources like dietary or consecutive antioxidants.
The human body employs three general categories of antioxidants to safeguard against free
radicals.  They  are  endogenous  antioxidants,  dietary  antioxidants,  and  metal-binding
proteins [16].
3.1. Endogenous antioxidants
These are categorized into primary antioxidants and secondary antioxidants. SOD, catalase,
and glutathione peroxidase are the primary antioxidant enzymes that inactivate the ROS into
intermediates [13]. Secondary antioxidant enzymes (glutathione reductase, glucose-6-phos‐
phate dehydrogenase, glutathione-s-transferase, and ubiquinone) detoxify ROS and supply
the NADPH and glutathione for primary antioxidant enzymes for proper functioning. Metals
such as copper, iron, manganese, zinc, and selenium up-regulate the antioxidant enzyme
activities [14, 15].
3.2. Exogenous antioxidants
Many polyphenolic compounds such as flavonoids, isoflavones, flavones, anthocyanins,
coumarins, lignans, catechins, isocatechins, epicatechins, and phenolic acids have gained
importance as antioxidant drugs [16]. Dietary antioxidants act through scavenging free
radicals to break the chain reaction responsible for lipid peroxidation. Vitamins C and E,
carotenoids, and flavonoids are the dietary antioxidants. These vitamins are also known as
chain-breaking antioxidants [16]. The metal-binding proteins (albumin, ferritin, and myoglo‐
bin) inactivate the transition metal ions that catalyze the production of free radicals [17, 18].
Antioxidant enzymes – catalase, SOD, glutathione peroxidase, glutathione reductase, and
thioredoxin – act against the ROS. The non-enzymatic antioxidants are the scavengers of ROS
and RNS [59].
3.3. Cellular antioxidant system
Lipid peroxidation is slowed down by the activity of chemical compounds that contain
monohydroxy/polyhydroxy phenol acting as antioxidants. These compounds have low
activation energy to donate the hydrogen atom and, therefore, cannot initiate the secondary
free radicals. The free radical electrons are stable and, thus, slow down the oxidation. Preven‐
tion of excessive ROS and repair of cellular damage are essential for the life of cells, and cells,
in turn, contain many antioxidant systems to prevent the oxidative injury [60, 61].
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3.4. Mechanism of action of antioxidants
2
R  AH RH  A
RO AH ROH A
ROO  AH ROOH A
R A RA
RO A ROA
ROO A ROOH
Antioxidant  O Oxidized antioxidant.
+ ® +
+ ® +
+ ® +
+ ®
+ ®
+ ®
+ ®
3.5. Mode of action of antioxidants
1. Primary or chain-breaking antioxidants: break chain reaction and the resulting radical are
less reactive
ROO AH ROOH A
ROOH A ROOA.
+ ® +
+ ®
2. Secondary or preventive antioxidants:
They may act either by
• Chelating/deactivating metals,
• Scavenging singlet oxygen (highly toxic), or
• Removing ROS.
Figure 4. A schematic diagram of the antioxidant defense mechanism (Adapted from [5]).
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ROS scavengers ROS protective enzymes Sequestration of transition
metal ions which form ROS
Glutathione Superoxide dismutase Transferrin
Uric acid Catalase Ferritin
Ascorbic acid Glutathione peroxidase Metallothionein
Albumin Glutathione reductase Ceruloplasmin
Table 2. Antioxidant defensive agents (Adapted from [66]).
Enzymatic antioxidants Reactions catalyzed
Superoxide dismutase (SOD) O2 _ + O2 + 2H →  2H2O2 + O2
Catalase (CAT) H2O2 →  H2O +1 /2O2
Glutathione peroxidase (GPX) H2O2+GSH →  H2O +GSSG
Glutathione reductase (GR) GSSG+NAD(P)H →  2GSH+ NAD(P)+
Table 3. Major ROS scavenging antioxidant enzymes (Adapted from [67]).
Antioxidants are present with protective efficiency. If there is an electron-donating group,
especially a hydroxyl group loaded on o- or p-positions of the phenolic compounds, it makes
the compound polar, and, therefore, antioxidant activities and metal chelating ability are
increased. These groups make the phenols more easily donate hydrogen atoms to activate free
radicals to interrupt the chain reaction of autoxidation. Antioxidants of natural origin such as
polyphenols (tannins, flavonoids, and chalcones) act by donating an electron to the intermedi‐
ate radicals formed in oxidative stress or tissue damage, which helps in the inhibition of lipid
peroxidation. A computational study also supports that the compounds having more electron
donating potentials are better inhibitors of hydroperoxides that suggest many of the antioxi‐
dant agents [62–67].
4. Antioxidants: Health and diseases
Several human pathologies such as neurodegenerative diseases, cancer, stroke, and many
other ailments are believed to be caused by ROS. Antioxidants are assumed to prevent the
harmful effects of ROS and therefore treat oxidative stress-related diseases (Figure 5).
Antioxidant approach to disease management holds potential as most of the diseases are
mediated through ROS; also with the rapid advancement of civilization, industrialization, and
overpopulation, there has been a significant rise in oxidative stressors. Epidemiological
researches strongly suggested that foods containing antioxidants and scavengers have a
potential protective effect against disorders caused by ROS [66]. Many chronic diseases can be
prevented, and disease progression can be slowed by increasing the body natural antioxidant
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defenses or by supplementing with dietary antioxidants. Natural antioxidants such as
flavonoids, tannins, and polyphenols act by donating electrons to intermediate radicals and
help in inhibition of lipid peroxidation. Antioxidants are essential to prevent the formation
and oppose the actions of reactive oxygen and nitrogen species, which are generated in vivo
and cause damage to DNA, lipids, proteins, and other biomolecules. The antioxidant system
contains exogenous antioxidants (dietary sources) and endogenous antioxidants.
4.1. Exogenous antioxidants as drugs
Many polyphenolic compounds such as flavonoids, isoflavones, flavones, anthocyanins,
coumarins, lignans, catechins, isocatechins, epicatechins, and phenolic acids have gained
importance as antioxidant drugs.
4.2. Role of dietary nutrients in defensive mechanism
Protein and amino acids play an important role in the synthesis of antioxidant enzymes. Small
peptides like GSH and carnosine and nitrogenous metabolites like creatine and uric acid
directly scavenge the reactive metabolites [67]. iNOS expression and synthesis in various cells
are controlled by taurine and taurine chloramines. Deficiency of dietary protein can have a
harmful effect on the antioxidant system of the cell. Arginine and tetrahydrobiopterin
deficiency directly affect the superoxide enzyme production. Decreased protein intake affects
the availability of zinc, which is a cofactor of SOD. Similarly, a high-protein diet exhibits
oxidative stress. Homocysteine increases inducible and constitutive NOS synthesis and
stimulates ROS generation in polymorphonuclear leukocytes and monocytic cells [68–70].
4.2.1. Lipids
There is a generation of ROS due to the intake of polyunsaturated fatty acids which are
neutralized by vitamins C and E and carotenoids. There is an increase in the risk of cardio‐
Figure 5. Oxidative stress-induced diseases in humans (Adapted from [65]).
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vascular diseases due to high intake of polyunsaturated fatty acids. On the other hand, a high-
saturated-fat diet increases the risk of iNOS activity in the liver and colon. Fish oil decreases
the cardiovascular risk by reducing triacylglycerol production in plasma as it contains ω-3
PUFA that is the inhibitor of ROS, iNOS expression, and NOS synthesis [71].
4.2.2. Vitamins
Vitamins exhibit anti-atherogenic and anti-inflammatory properties. Vitamin A inhibits iNOS
in vascular muscle cells, endothelial cells, cardiac myocytes, and mesangial cells. Vitamins D3,
K2, and niacin inhibit iNOS activity in the neuronal cells (macrophage, microglia, and
astrocytes) Lipid peroxidation of the membrane is prevented by vitamin E as it inhibits the
ROS generation. Irradiation decreases the concentration of vitamin C and folate, thus leading
to ROS generation. It has been reported that vitamin B12 and folic acid reduce radical-induced
radiation damage and improve leukocyte counts. DNA damage and hepatocellular carcinoma
are prevented by vitamin C and choline. Vitamins B12, B6, and folate are essential for the
synthesis of cystathionine synthase and cystathionase (B6) and methionine synthase (B12).
These vitamins prevent cardiovascular diseases in humans and rodents. NADP, NADH, FAD,
nicotinamide, and riboflavin protect the cells from ROS generation. NADPH and FAD are
essential for glutathione reductase. NADPH is required for catalase activity [70–75].
4.2.3. Micronutrients and minerals
Copper, zinc, and manganese, the important trace elements in our body, serve as cofactors of
SOD enzyme. Deficiency of either copper or zinc increases the cytochrome P450 activity in
microsomes of the liver and lungs, and thus increases the generation of ROS and iNOS
expression [76]. Selenium possesses potential antioxidant activity as it is a cofactor of gluta‐
thione transferase enzyme and other selenoproteins.
4.3. Phytochemicals
Many medicinal plants contain phytochemicals like phenolic and polyphenolic compounds
such as flavonoids, isoflavones, flavones, anthocyanins, coumarins, lignans, catechin, isocate‐
chin, gallic acid, and esculatin that possess antioxidant activities [77]. These phytochemicals
are present in many plants and herbs like grapes, berry crops, tea, herbs, nutmeg, and tea.
Many medicinal plants contain phenolics like gallic acids and other active constituents.
Terminalia chebula, T. bellerica, T. muelleri, Phyllanthus emblica, Hemidesmus indicus, Cichorium
Intybus, Withania somnifera, Ocimum sanctum, Mangifera indica, and Punica granatum are known
to have potential antioxidant activities [78].
5. Antioxidant therapy
Recent human studies exploring the efficiency of antioxidants in prevention and treatment of
various diseases are reviewed (Table 4).
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Disease studied Antioxidant used Reference Reference no.
Mortality:
Primary/Secondary Prevention
Beta-carotene, vitamin A, vitamin C, vitamin E,
and selenium
Bjelakovic et al. [79]
Fatty liver disease Vitamin A, carotenoids, vitamin C, vitamin E
and selenium
Lirussi et al. [80]
Amyotrophic Lateral Sclerosis
(SLA)
Vitamin E 500 mg twice daily Orrell et al. [81]
Multiple Sclerosis Omega-6 fatty acids (11-23 g/day linoleic acid) Farinotti et al. [82]
Alcoholic Liver Disease S-adenosyl-L-methionine Rambaldi et al. [83]
Oncology Treatments Selenium Dennert et al. [84]
Eye Related Macular Disease Beta-carotene and alpha-tocopherol. Evans et al. [85]
Pregnancy and Pre-eclampsia Vitamin C and vitamin E supplements Poston et al. [86]
Cardiovascular Risk Profile Dietary antioxidants EJ Brunner et al. [87]
Neonatal Growth Under
Parenteral Nutrition (PN)
Cysteine, cystine or its precursor N-
acetylcysteine
Soghier et al. [88]
Melatonin and Cognitive
Impairment or dementia
Melatonin Jansen et al. [89]
Alzheimer Disease Vitamins C or E Gray et al. [90]
Parkinson Disease Tocopherol, CoQ10, and glutathione. Weber et al. [91]
. Cancer Lipid-soluble antioxidant vitamins, Kirsh et al. [92]
Asthma Vitamin C, manganese etc. Patel et al. [93]
Cardiovascular Diseases Vitamins C and E Berhendt et al. [94]
Ischemia-Reperfusion Injury Vitamin C. Pleiner et al [95]
Chronic Obstructive Pulmonary
Disease (COPD)
Polyphenol-rich pomegranate juice (PJ) Cerda et al. [96]
Pancreatitis Selenium, L-methionine, and vitamins C and E, Kirk et al. [97]
Rheumatoid Arthritis Vitamins A, C, E or selenium or their
combination
Canter et al. [98]
Kidney Diseases Vitamin E Ong-ajyooth et al. [99]
Liver Diseases Antioxidant therapy Gabbay et al. [100]
Diabetes Type I and II Probucol and statins Endo et al. [101]
Table 4. The efficiency of antioxidants in prevention and treatment of various diseases.
Many of these studies, either due to the small patient sample size, with uncontrolled admis‐
sions and treatment criteria, or due to relevant bias of the clinical studies failed to give precise
information on effectiveness and practical advantage in taking antioxidants.
Antioxidants therapies have been in progress these days. Edaravone (for ischemic stroke), N-
acetylcysteine (for acetaminophen toxicity), alfa-lipoic acid (for diabetic neuropathy), and
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some flavonoids (for chronic venous insufficiency) as well as baicalein and catechins (for
osteoarthritis) have clinical importance. The evidence from human epidemiological studies
about the beneficial effects of dietary antioxidants and preclinical in vitro and animal data are
compelling. Attention needs to be drawn on focusing more on disease-specific, target-directed,
highly bioavailable antioxidants [102]. In the recent years, due to the increase in the consump‐
tion of food and medicinal products, we are exposed to the adverse effects of various com‐
pounds noticed in the above products. For example, in our animal experimental studies, we
have determined induction of oxidative stress induced by the compound cinnamaldehyde, a
food flavor and also an anticancer drug [103–105]. As a therapeutic measure, addition of
vegetables and fruits, the great sources of vitamins or antioxidants, in our routine diet might
protect our health from toxic effects of food chemicals or drugs to a certain extent [106].
5.1. Oxidative stress test
In this advanced materialistic life, monitoring the levels of free radicals and oxidative stress is
important in case of clinical practice. FORD (Free Oxygen Radicals Defense) is an easy, cheap,
and reliable diagnostic device to monitor oxidative stress [19, 107]. It discriminates the high
risk of oxidative damage on sick or healthy individuals, monitoring with precise laboratory
parameters in the clinical situation at the baseline and in the follow-up of a medical prescrip‐
tion.
FORD (Free Oxygen Radicals Defense) is a colorimetric test based on the influence of antiox‐
idants present in plasma to reduce the activity of free radicals. The principle of the assay is
that at an acidic pH (5.2) and in the presence of a suitable oxidant solution (FeCl3), 4-amino-
n, n- diethylaniline, the FORD chromogen, can form a stable and colored radical cation.
Antioxidant molecules (AOH) present in the sample which are able to transfer a hydrogen
atom to the FORD chromogen radical cation, reduce it, quenching the color and producing a
discoloration of the solution which is proportional to their concentration in the sample. This
instrument will be helpful in understanding the problem of the individual bioavailability of
each antioxidant molecule which can be monitored during the administration, with a pre-post
measure of the oxidative balance. In order to achieve the evidence of the oxidative background
related to the outcome of specific symptoms and diseases, epidemiological studies can be
encouraged, and the role of nutrition and targeted antioxidant therapy can be better defined.
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